Successful treatment of sequential therapy in digital Bowen's disease with methyl aminolevulinate photodynamic therapy and topical diclofenac 3% in hyaluronan 2.5% gel.
Dermatology Service, Hospital de Barbastro, Huesca, Spain.
Tamara
T
Gracia-Cazaña
Dermatology Service, Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain.
María Teresa
MT
López
Pathology Service, Hospital de Barbastro, Huesca, Spain.
Rosa
R
Oncins
Dermatology Service, Hospital San Jorge, Huesca, Spain.
Yolanda
Y
Gilaberte
D000287:Administration, Topical; D000369:Aged, 80 and over; D000622:Aminolevulinic Acid / Q000008:administration & dosage / Q000031:analogs & derivatives*; D001706:Biopsy; D001913:Bowen's Disease / Q000175:diagnosis / Q000188:drug therapy*; D052246:Cyclooxygenase 2 Inhibitors / Q000008:administration & dosage*; D004008:Diclofenac / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D010778:Photochemotherapy / Q000379:methods*; D017319:Photosensitizing Agents / Q000008:administration & dosage*; D012074:Remission Induction; D012878:Skin Neoplasms / Q000175:diagnosis / Q000188:drug therapy*; D014034:Toes; D016896:Treatment Outcome
D052246:Cyclooxygenase 2 Inhibitors; D017319:Photosensitizing Agents; D004008:Diclofenac; C475457:methyl 5-aminolevulinate; D000622:Aminolevulinic Acid
Bowen's disease; diclofenac; photodynamic therapy; therapeutics